COPD is a major public health problem , and it results with an extensive social and
economical burden on both the patient and his family on one hand and the healthcare
system on the other . Despite the great advances in the management of patients w
ith COPD
, the use of the optimal treatment of the proposed treatment options is still being discussed ,
and Must achieve greater benefit for both patients and the healthcare system .
This research is designed to study and compare the effect of the combination
(salbutamol and ipratropium bromide) with the effect of salbutamol alone in the treatment
of patients with stable COPD , by studying and comparing the improvement in the forced
expiratory volume in the first second (FEV1) and in forced vital capacity
( FVC) after a month of a treatment .
The study included 80 patients (53 males and 27 females), the patients were between
45-81 years of age , 63 patients were smokers and 17 were nonsmokers.
The study showed that after a month on therapy , for patients treated with the
combination (salbutamol + ipratropium bromide) the increasing in FEV1 was 0.35 liters
and in FVC was 0.61-liter , while , for the patients treated with salbutamol alone , the
increasing in FEV1 was 0.28 liters and FVC was 0.48-liter .
We concluded that a combination of ipratropium bromide and salbutamol is more
effective at improving pulmonary function than salbutamol alone.
Asthma exacerbations can be frequent and range in severity from relatively mild to
status asthmaticus. While the efficacy of intravenous MgSO4 hasbeen demonstrated, the
informations available on its inhaled role still low and conflicting, so the st
udy aim to
investigate the effect of thecombinationof MgSO4and salbutamol in the management of
acute asthma attack.
A randomized clinical trial was conducted on 76 patients, divided into two groups:
experimental (40) and control (36) patients. The trial received nebulised salbutamol with
magnesium sulphate and control nebulised salbutamol with saline serum 0.9% on three
sessions in 20 minutes. Signs of respiratory distress, wheezing, respiratory rate, pulse,
Sao2 and PEF were assessed.
Magnesium sulphate showed a significant effect in improving respiratory rate, Sao2
and PEF starting from the 20th minute( P <0.05), but did not observe the effect of MgSO4
in improving signs of respiratory distress, pulse and wheezing(P> 0,05), no side effects
attributed to magnesium sulphate were observed.Inhaled MgSO4, incombination with
salbutamol, appears to have benefits in the treatment of acute asthma attack.
